a service announcement from Pharmexec
Pharmexec logo

HYALURON


Please join HCM for a Live Webcast
March 25, 2010 – 11:00 AM EST

HYALURON
Comparison of CCI of Syringes and Vials during Transport

Understand more about the container closure integrity of syringes/vials during the transport
and the possible outcomes:


It has been shown that during air transport of pre-filled syringes, the stoppers are prone to move in response to changes in ambient pressure. This puts in question the container closure integrity of syringes exposed to reduced pressure. A syringe stopper may move back under reduced pressure and possibly pull contaminants back into the product as the stopper returns to its original position when the reduced pressure is removed. The phenomenon is not observed with vials since the stopper is held in place. This might suggest that a vial is a more rugged container under reduced pressure than a syringe. In this study we demonstrate that with appropriate control over the gas headspace in a syringe the stopper movement can be reduced to negligible. Further we show that if a true CCI failure exists a syringe is a better container to prevent contamination than is a vial.

Register Now!

Event Sponsor: Nuova Ompi: Stevanato Group

 

For more information:
Visit the Hyaluron website
Email Hyaluron
Phone: 781.270.7900 x 187
Fax: 781.270.0110

Hyaluron Contract Manufacturing
99 S. Bedford Street
Burlington, MA 01803

If you no longer wish to receive emails from Hyaluron Contract Manufacturing, Please reply here with "unsubscribe" in the subject line.

Pharmaceutical Technology is published by Advanstar Communications, 485 Rt 1 South, Iselin, NJ 08830.
This is an advertisement sent on behalf of this advertiser.